Tag: drug development

Pharmaceutical Companies Repurposing Drugs to Accelerate Growth

The drug development process can be incredibly costly, both in terms of the financial commitment required and the time necessary...

5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top

MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology...

Resverlogix CEO Discusses Phase 3 BETonMACE Clinical Trial

Aside from the recent funding and Phase 3 trial news, Resverlogix has many milestones for investors to look forward to...

Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis

Isodiol International LLC (CSE:ISOL, OTC:ISOLF, FSE:LB6A.F) (the “Company” or “Isodiol”), a global innovator specializing in the development of pharmaceutical and...

Scythian Biosciences Announces Licensing Agreement With Isodiol International Inc.

Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that it has...

Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis

Isodiol International LLC (CSE:ISOL, OTC:ISOLF, FSE:LB6A.F) (the “Company” or “Isodiol”), a global innovator specializing in the development of pharmaceutical and...

Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the U.S. Patent and Trademark Office ("USPTO") issued...